Live Breaking News & Updates on A Family Of Randomised Trials Set To Enrol 279 And 219 Patients Respectively

Tampa (Florida) [US], December 3 (ANI/PRNewswire): VEITH 2022 witnessed a surge of supporting clinical data for Sirolimus Coated Balloon in the treatment of Below-the-Knee (BTK) disease. Concept Medical Inc. hosted a lunch symposium titled 'Sirolimus Coated Balloon in PAD Treatment: Choice of The Future' which explored the utility of Sirolimus Coated Balloon treatment in PAD. The session was chaired by Prof. Sahil Parikh, co-moderated by Prof. Edward Choke and Prof. Aloke Finn with interesting presentations by Prof. Ulf Teichgraber and Prof. Francesco Liistro. One of the highlights of the session was the follow up data of clinical outcomes of the XTOSI Trial. XTOSI (Xtreme Touch Sirolimus coated PTA balloon) is a single arm trial for Sirolimus Coated Balloon (MagicTouch PTA) investigating the clinical use and safety of the device in the treatment of infrainguinal Peripheral Arterial Disease (PAD). This prospective, premarket, non-randomized, all comers single-arm study, led by ....

New York , United States , Aloke Finn , Francesco Liistro , Ulf Teichgraber , Sahil Parikh , Concept Medical Inc , Sirolimus Coated Balloon , Edward Choke , Xtreme Touch Sirolimus , Peripheral Arterial Disease , Magic Touch , Coated Balloon , Sengkang General Hospital , Sirolimus Coated , New York Times Square , Tampa Florida Us , Ecember 3 Ani Prnewswire Veith 2022 Witnesseda Surge Of Supporting Clinical Data For Sirolimus Coated Balloon In The Treatment Below Knee Btk Disease Concept Medical Inc Hosteda Lunch Symposium Titled 39 Pad Choice Future Which Explored Utility Session Was Chaired By Prof Sahil Parikh , O Moderated By Prof Edward Choke And Aloke Finn With Interesting Presentations Ulf Teichgraber Francesco Liistro One Of The Highlights Session Was Follow Up Data Clinical Outcomes Xtosi Trial Xtreme Touch Sirolimus Coated Pta Balloon Isa Single Arm For Magictouch Investigating Use Safety Device In Treatment Infrainguinal Peripheral Arterial Disease Pad This Prospective , On Randomized , Ll Comers Single Arm Study , Ed By Pi Prof Edward Choke Enrolled 50 Patients To Study The Magic Touch Pta Sirolimus Coated Balloon Concept Medical Inc At Sengkang General Hospital , Ingapore It Is The World 39s First Trial Of Sirolimus Coated Balloon For Btk Disease And Has Longest Follow Up Data While Primary Endpoints Already Suggested Promising Patency Safety At 6 Months , He Data Presented At Veith 2022 Shed More Light On The Longer Term Efficacy And Safety Of Sirolimus Coated Balloon Prof Edward Choke , Urther Presented Updates On The Future Sfa And Btk Rcts , A Family Of Randomised Trials Set To Enrol 279 And 219 Patients Respectively ,